Medical Dermatology
Latest News
Studies validate IL-17 as hidradenitis suppurativa drug target
This clearly validates this target for the control of HS," reported lead investigator Alexa B. Kimball, MD, MPH.
Latest News
Novel single-use patch shows promise for primary axillary hyperhidrosis
“This is a new kind of device that is going to be a nice tool to have.”
Latest News
JAK inhibitor safety warnings drawn from rheumatologic data may be misleading in dermatology
The recently approved deucravacitinib is the only JAK inhibitor that has so far been exempt from these warnings.
The Optimized Doctor
How to become wise
Wise is more than being brilliant at bullous diseases or knowing how to sleep train a baby.
Latest News
Study finds quality of topical steroid withdrawal videos on YouTube subpar
“We were disheartened that patient testimonial videos had the poorest quality and reliability of the information sources,” Erika McCormick said....
Conference Coverage
Nearly one in three patients with IBD affected by skin lesions
“Skin lesions in IBD patients are much more prevalent than it is generally accepted. The lesions may be related to the pathogenesis of IBD, but it...
Latest News
Silicone-based film for radiation dermatitis: It works, so why isn’t it used?
Use of the film significantly reduced the incidence of grade 2 or 3 radiation dermatitis in a study of women with breast cancer.
Make the Diagnosis
White male presents with pruritic, scaly, erythematous patches on his feet and left hand
A 47-year-old patient presents with pruritic, scaly, erythematous patches on his feet and left hand.
Latest News
FDA to review dupilumab for treating chronic spontaneous urticaria
Dupilumab enters the approval process for adolescents and adults with uncontrolled CSU.
Latest News
FDA accepts application for topical molluscum treatment
A new drug application for berdazimer gel 10.3% for the treatment of molluscum will be reviewed by the FDA.
From the Journals
Antibiotics and SJS/TEN: Study provides global prevalence
Sulfonamides responsible for the highest proportion of antibiotic-triggered Stevens-Johnson syndrome and toxic epidermal necrolysis.